Body composition dynamics and impact on clinical outcome in gastric and gastro-esophageal junction cancer patients undergoing perioperative chemotherapy with the FLOT protocol

被引：0
|
作者：
Florian Huemer
Stefan Hecht
Bernhard Scharinger
Verena Schlintl
Gabriel Rinnerthaler
Konstantin Schlick
Ronald Heregger
Thomas Melchardt
Angela Wimmer
Iris Mühlbacher
Oliver Owen Koch
Daniel Neureiter
Eckhard Klieser
Sara Seyedinia
Mohsen Beheshti
Richard Greil
Lukas Weiss
机构：
[1] Paracelsus Medical University Salzburg,Department of Internal Medicine III with Haematology, Medical Oncology, Haemostaseology, Infectiology and Rheumatology, Oncologic Center, Salzburg Cancer Research Institute , Center for Clinical Cancer and Immunology
[2] Cancer Cluster Salzburg,CCCIT)
[3] Paracelsus Medical University Salzburg,Department of Radiology
[4] Paracelsus Medical University Salzburg,Department of Surgery
[5] Paracelsus Medical University Salzburg,Institute of Pathology
[6] Paracelsus Medical University Salzburg,Division of Molecular Imaging and Theranostics, Department of Nuclear Medicine
来源：
Journal of Cancer Research and Clinical Oncology | 2023年 / 149卷
关键词：
Gastric cancer; Perioperative chemotherapy; Sarcopenia; Skeletal muscle index; Body mass index;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：3051 / 3064
页数：13
相关论文
共 50 条
  • [31] A phase-Ib study of TRK-950 combined with anticancer treatment regimens in patients with gastric and gastro-esophageal junction (GEJ) cancer.
    Cassier, Philippe Alexandre
    Matrana, Marc Ryan
    Hanna, Diana L.
    George, Ben
    Sharma, Sunil
    Kelly, Ronan Joseph
    Okano, Fumiyoshi
    Von Hoff, Daniel D.
    Blay, Jean-Yves
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 : 361 - 361
  • [32] Efficacy and safety of PD-1/PD-L1 inhibitors combined with chemotherapy in patients with advanced gastric or gastro-esophageal junction cancer: A systematic review and meta-analysis
    Su, Shiqing
    ONCOLOGY LETTERS, 2023, 26 (03)
  • [33] Systematic Review and Meta- Analysis of Randomized Controlled Trials on Primary Outpatient Thromboprophylaxis (POTP) in Patients with Gastric and Gastro-Esophageal Junction (GEJ) Cancers Receiving Chemotherapy
    Thein, Kyaw Zin
    Htut, Thura Win
    Han, Myat Min
    Myat, Yin Mon
    Win, Myint Aung
    Phyu, Ei Moe
    Oo, Thein H.
    BLOOD, 2022, 140 : 10887 - 10888
  • [34] PD-L1 mRNA expression in patients with resectable gastric cancer and adenocarcinoma of the oesophago-gastric junction undergoing perioperative chemotherapy: Results from the FLOT4 phase III trial of the AIO.
    Waberer, Lisa
    Homann, Nils
    Wirtz, Ralph M.
    Schmalenberg, Harald
    Haag, Georg Martin
    Schuler, Martin H.
    Kasper, Stefan
    Goetze, Thorsten Oliver
    Pauligk, Claudia
    Hofheinz, Ralf
    Al-Batran, Salah-Eddin
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [35] Body Composition as a Prognostic Factor of Neoadjuvant Chemotherapy Toxicity and Outcome in Patients with Locally Advanced Gastric Cancer
    Palmela, Carolina
    Velho, Sonia
    Agostinho, Lisa
    Branco, Francisco
    Santos, Marta
    Costa Santos, Maria Pia
    Oliveira, Maria Helena
    Strecht, Joao
    Maio, Rui
    Cravo, Marilia
    Baracos, Vickie E.
    JOURNAL OF GASTRIC CANCER, 2017, 17 (01) : 74 - 87
  • [36] Prognostic relevance of prognostic nutritional indices in gastric or gastro-esophageal junction cancer patients receiving immune checkpoint inhibitors: a systematic review and meta-analysis
    Hou, Shufu
    Song, Dandan
    Hao, Ruiqi
    Li, Linchuan
    Zhang, Yun
    Zhu, Jiankang
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [37] QUALITY OF LIFE RESULTS FROM A PHASE III STUDY OF TRASTUZUMAB PLUS CHEMOTHERAPY AS FIRST-LINE THERAPY IN PATIENTS WITH HER2-POSITIVE ADVANCED GASTRIC AND GASTRO-ESOPHAGEAL JUNCTION CANCER
    Ohtsu, A.
    Wang, L.
    Lim, H.
    Gourbounova, V
    Bang, Y.
    Van Cutsem, E.
    Al-Sakaff, N.
    Lehle, M.
    Hill, J.
    de Mendoza, Hurtado F.
    ANNALS OF ONCOLOGY, 2010, 21 : 14 - 14
  • [38] Intensifying peri-operative chemotherapy with radiotherapy in resectable gastro-esophageal junction (GEJ) and stomach cancer patients: Initial results of a prospective trial at a tertiary cancer care centre
    Pant, S.
    Kumar, Y.
    Misra, S.
    Singh, S.
    Singh, R.
    Kumar, S.
    ANNALS OF ONCOLOGY, 2020, 31 : S165 - S165
  • [39] A phase 2 single-arm study of berzosertib in combination with irinotecan in patients with progressive TP53 mutant gastric and gastro-esophageal junction cancer
    Stockton, Shannon
    Soares, Heloisa P.
    Dayyani, Farshid
    Saeed, Anwaar
    Kim, Edward S.
    Jin, Ning
    Yacoub, George Hosni
    Whisenant, Jennifer
    Ayers, G. Dan
    Gore, Steven
    Das, Satya
    Berlin, Jordan
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [40] Gastric Inflammatory Prognostic Index (GIPI) in Patients with Metastatic Gastro-Esophageal Junction/Gastric Cancer Treated with PD-1/PD-L1 Immune Checkpoint Inhibitors
    Formica, Vincenzo
    Morelli, Cristina
    Patrikidou, Anna
    Murias, Carmen
    Butt, Sabeeh
    Nardecchia, Antonella
    Lucchetti, Jessica
    Renzi, Nicola
    Shiu, Kai-Keen
    Roselli, Mario
    Arkenau, Hendrik-Tobias
    TARGETED ONCOLOGY, 2020, 15 (03) : 327 - 336
12345